Next Quarterly Earnings
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
BeOne Medicines, an innovative pharmaceutical company headquartered in Switzerland, is dedicated to the research and development of novel therapies. The company focuses on biotechnological approaches to create groundbreaking medicines for specific diseases, aiming to sustainably improve the quality of life for patients worldwide. Its expertise lies in the discovery and clinical development of pioneering pharmaceutical solutions.
Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
BeOne Medicines is scheduled to report its next quarterly earnings on 11/05/2026. Pre-market — typically early morning before trading starts (around 7–8 a.m. CET).
BeOne Medicines last reported quarterly earnings on 8/5/2026 (Q2 2026). Earnings per share (EPS) came in at 1.24 HKD.
BeOne Medicines has beaten analyst EPS estimates in 2 of its last 3 evaluated quarters (beat rate: 66.7%).
Use the 'Subscribe in calendar' button on this page to add all dates to Google Calendar, Apple Calendar or Outlook. Dates update automatically when they change.
Basis: 3 quarters with an analyst estimate and reported EPS.
Past price reactions are not a reliable indicator of future performance.